Perfumania Holdings Inc (PERF:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Key Findings: - Unique new report provides deep financial benchmarks for (Perfumania Holdings Inc (PERF:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. - Benchmarking study for (Perfumania Holdings Inc ) includes growth forecast for its primary industry to the year 2024.
The purpose of this report is to provide vital corporate-specific benchmarks, comparing the Subject Company to its top competitors (on a company-by-company basis) and to the averages within its primary industry for all key metrics.
This is a unique report containing high-value data. The report begins with a superb overview of the primary industry of the Subject Company, including historical industry revenues, revenue forecasts and CAGR. Then the report moves into industry averages and metrics, then into data specific to the Subject Company, with comparative data for the Subject Company’s top competitors. This report will save countless hours of research and analytical work for the end user.
Core Benefits to Customer: 1) Comprehensive benchmarks for the Subject Company: a. Benchmarked against the leading firms in its primary industry b. Benchmarked against the average for publicly-held companies (U.S.) in its industry. c. This includes financial results, ratios, vital statistics and metrics in one package, including historical and current metrics and averages for 6 years within its primary industry. 2) A snapshot overview of the company’s primary industry, including current and historic revenues and employment, along with a long term forecast for industry growth, with CAGR (compound annual growth rate), employee population and much more. 3) Detailed rankings of the Subject Company against top companies within the industry (U.S.-based firms) for key items including: a. Approximate market capitalization b. Employees c. Revenues d. Net income e. 3-Year revenue growth (%) f. 3-Year income growth (%) g. Return on assets (%) h. Return on equity (%) i. Return on invested capital (%) 4) Leading companies-profiles of the Subject Company as well as profiles of top competitors within the industry
This report is part of the Plunkett’s Corporate Benchmarks series, published by the Plunkett Analytics unit of Plunkett Research, Ltd. Plunkett Research has unique capabilities for creating corporate and industry information, due to the industry and company research that we have been conducting for more than 20 years. Our access to hundreds of industry tables from our own databases, along with our databases of public and private company information, industry trends analysis and other resources, have been utilized in preparing this report. Similar reports are available for all significant, U.S. publicly-held firms.
Designed to benefit: - Analysis and Financial Modeling -Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants
Companies Profiled: - CVS Health Corporation - Walgreens Boots Alliance Inc - Rite Aid Corporation - Omnicare Inc - Diplomat Pharmacy Inc - Sally Beauty Holdings Inc - Ulta Beauty Inc - Mead Johnson Nutrition Company - Bath & Body Works LLC - GNC Holdings Inc
Our reports have been used by over 10K customers, including:
Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Glaucoma Treatment Market. The report analyzes the global glaucoma treatment market By Indication...
172 pages •
By Global Industry Analysts
• Jan 2019
This report analyzes the worldwide markets for ePharmacies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year...
300 pages •
By The Business Research Company
• Jan 2019
Pharmacies and Healthcare Stores Market Global Report 2019 provides the strategists, marketers and senior management with the critical information they need to assess the global pharmacies and healthcare stores market. Description: Where is the largest and fastest growing market for the pharmacies and healthcare...
49 pages •
By Euromonitor International
• Dec 2018
Although Latin America saw slower growth in adult incontinence than most other regions over the review period, economic recovery, increased consumer awareness and favourable demographic trends all point to higher growth in the forecast period. With a significant untapped consumer base, there is much room for growth; however, pricing and affordability...
Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2025, NAIC 446000 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save...
Pharmacies and Drug Stores Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2025, NAIC 446110 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: -...
38 pages •
By Euromonitor International
• Jan 2019
Distribution of consumer health products is at once both remarkably static and ceaselessly dynamic, depending on where you look. Regulations and cultural norms are keeping growth through store-based retailing consistent across channels. Innovations around improved delivery time horizons, more payment options, and digital health and tracking...
The 2019 World Industry & Market Outlook report is the leading annual publication that describes over 100 major world industries and 500+ minor industries. Sixty-one countries are included as well as the proprietary 2019 Worldwide Economic Forecast executive summary. Published each year in November, the Outlook report...
Compounding factors: Drug shortages and an aging population will combine to benefit the industry Abstract Compounding Pharmacies Despite some negative media attention over the five years to 2018 due to cases of contaminated prescriptions, the Compounding Pharmacies industry has grown thanks to its...
Active immunity: The aging population will strengthen industry revenue Abstract Institutional Pharmacies The Institutional Pharmacies industry is relatively immune to fluctuations in the macroeconomic climate due to its nondiscretionary nature. However, the industry experienced some declines in...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.